Efficacy and safety of 0.18% sodium hyaluronate in patients with moderate dry eye syndrome and superficial keratitis.
about
Over the counter (OTC) artificial tear drops for dry eye syndromeSynergistic Effect of Artificial Tears Containing Epigallocatechin Gallate and Hyaluronic Acid for the Treatment of Rabbits with Dry Eye SyndromeHLA-DR expression as a biomarker of inflammation for multicenter clinical trials of ocular surface diseaseEfficacy of the mineral oil and hyaluronic acid mixture eye drops in murine dry eye.Efficacy and safety of two new formulations of artificial tears in subjects with dry eye disease: a 3-month, multicenter, active-controlled, randomized trial.Performance profile of sodium hyaluronate in patients with lipid tear deficiency: randomised, double-blind, controlled, exploratory study.Therapeutic efficacy of trehalose eye drops for treatment of murine dry eye induced by an intelligently controlled environmental systemEffect of 0.3% Hydroxypropyl Methylcellulose/Dextran Versus 0.18% Sodium Hyaluronate in the Treatment of Ocular Surface Disease in Glaucoma Patients: A Randomized, Double-Blind, and Controlled Study.Efficacy of Carboxymethylcellulose and Hyaluronate in Dry Eye Disease: A Systematic Review and Meta-Analysis.Therapeutic Effects of Sodium Hyaluronate on Ocular Surface Damage Induced by Benzalkonium Chloride Preserved Anti-glaucoma MedicationsComparison of the Anti-Inflammatory Effects of Artificial Tears in a Rat Model of Corneal Scraping.Short term effects of topical cyclosporine and viscoelastic on the ocular surfaces in patients with dry eyeEffectiveness of sodium hyaluronate eye gel in patients with dry eye disease: a multi-centre, open label, uncontrolled study.New agents for treating dry eye syndrome.Emerging drugs for the treatment of dry eye disease.Current Approach to Dry Eye Disease.Recommendations for the treatment of Sjögren's syndrome.Sodium Hyaluronate in the Treatment of Dry Eye Syndrome: A Systematic Review and Meta-Analysis.Osmoprotectants, carboxymethylcellulose and hyaluronic acid multi-ingredient eye drop: a randomised controlled trial in moderate to severe dry eye.Topical and systemic medications for the treatment of primary Sjögren's syndrome.Effects of eye drops containing a mixture of omega-3 essential fatty acids and hyaluronic acid on the ocular surface in desiccating stress-induced murine dry eye.Timolol maleate release from hyaluronic acid-containing model silicone hydrogel contact lens materials.Management of post-LASIK dry eye: a multicenter randomized comparison of a new multi-ingredient artificial tear to carboxymethylcellulose.Comparative study of 0.1% hyaluronic acid versus 0.5% carboxymethylcellulose in patients with dry eye associated with moderate keratitis or keratoconjunctivitis.
P2860
Q24186110-3231C1E2-ABE5-4D15-BCB3-7C02C5D72EA0Q28552083-FAAB6F3D-0644-474B-8975-488CD36CD215Q33861286-84F5D83A-CA2D-41DB-B624-F8E03AF4FF37Q35205741-BC8D27F7-09EA-49CA-9319-8563E1A87D81Q35507058-DF7965D1-0CA1-495F-B2FA-1EB293CED812Q35762862-F0591487-7D4E-424B-B7CD-4FB5D00A475DQ35768484-27FBB081-ED75-4E71-8B25-6DD2157A1653Q35865215-C9E2530B-ADA6-4BE9-8BD1-37EC7A01F112Q36280601-4EC78507-0373-48BB-B807-31C62337BC90Q36498525-45EE13A1-EBA1-4B21-9038-3455D6CE94CDQ36656777-3ECDC3CE-4FA7-4EB9-870E-0D4D0BCE0611Q37070035-87B37F2B-EF62-4163-8C7E-D08F8BF036EEQ37280480-F83CD216-5BD4-481D-8D32-3360CD6C2915Q38058002-5D966D42-75A6-4BC3-85AC-EED36F1B4DD1Q38102006-48CD28AF-8FDD-408F-9BC9-5EC6028C64AAQ38235721-05C1CE53-985D-4F22-A9F3-823CD46E57DDQ38584878-5B096F14-2A07-4BAB-B3B7-2E04888D4BDDQ41489266-C9BCB4ED-B1F3-4037-AD1C-ADA1FEC1E839Q42702543-BBF0B787-3D5B-40CD-8445-2B6836DCDFD7Q44498935-FDEC8855-5A59-438F-A249-140F9B2DA057Q52647972-8A382F11-4F2B-4ABB-AB39-49E9B5009A98Q53259773-A27371A0-CAF5-4497-A33C-481FB100ACB6Q53818675-74AD50E8-D8D9-4627-9F00-D99FFD9952EAQ55250864-F025068B-C223-46FB-A351-326E3840D6CE
P2860
Efficacy and safety of 0.18% sodium hyaluronate in patients with moderate dry eye syndrome and superficial keratitis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Efficacy and safety of 0.18% s ...... ome and superficial keratitis.
@en
type
label
Efficacy and safety of 0.18% s ...... ome and superficial keratitis.
@en
prefLabel
Efficacy and safety of 0.18% s ...... ome and superficial keratitis.
@en
P2093
P1476
Efficacy and safety of 0.18% s ...... rome and superficial keratitis
@en
P2093
Bénédicte Dupas
Pierre-Jean Pisella
Vincent Baeyens
P2888
P304
P356
10.1007/S00417-004-1040-6
P577
2004-12-17T00:00:00Z